Published in Cancer Weekly, January 14th, 2003
"To better elucidate this matter, fresh biopsy samples from 21 patients - 10 with MYCN-amplified tumors (defined as having > 10 copies of the oncogene) and 11 with nonamplified tumors - were tested for their angiogenic capacity using the chick embryo chorioallantoic membrane assay, a useful model for such investigation.
"Moreover, using the same...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.